RhumbLine Advisers’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$225K Buy
21,226
+115
+0.5% +$1.22K ﹤0.01% 3164
2025
Q1
$317K Sell
21,111
-1,136
-5% -$17.1K ﹤0.01% 2851
2024
Q4
$366K Sell
22,247
-109
-0.5% -$1.79K ﹤0.01% 2864
2024
Q3
$552K Sell
22,356
-1,875
-8% -$46.3K ﹤0.01% 2637
2024
Q2
$614K Sell
24,231
-17
-0.1% -$431 ﹤0.01% 2530
2024
Q1
$616K Sell
24,248
-951
-4% -$24.2K ﹤0.01% 2532
2023
Q4
$571K Sell
25,199
-832
-3% -$18.9K ﹤0.01% 2585
2023
Q3
$485K Sell
26,031
-25,682
-50% -$478K ﹤0.01% 2629
2023
Q2
$1.34M Buy
51,713
+2,391
+5% +$62.1K ﹤0.01% 2143
2023
Q1
$1.42M Buy
49,322
+3,497
+8% +$100K ﹤0.01% 1983
2022
Q4
$1.36M Buy
45,825
+508
+1% +$15K ﹤0.01% 1989
2022
Q3
$1.08M Buy
45,317
+1,502
+3% +$35.8K ﹤0.01% 2092
2022
Q2
$978K Buy
43,815
+759
+2% +$16.9K ﹤0.01% 2152
2022
Q1
$1.08M Buy
43,056
+1,013
+2% +$25.4K ﹤0.01% 2102
2021
Q4
$1.51M Sell
42,043
-307
-0.7% -$11K ﹤0.01% 2027
2021
Q3
$1.8M Sell
42,350
-4,474
-10% -$190K ﹤0.01% 1968
2021
Q2
$2.03M Sell
46,824
-3,902
-8% -$169K ﹤0.01% 1942
2021
Q1
$2.07M Buy
50,726
+2,181
+4% +$89K ﹤0.01% 1890
2020
Q4
$2.2M Buy
48,545
+4,854
+11% +$220K ﹤0.01% 1805
2020
Q3
$1.55M Sell
43,691
-2,893
-6% -$102K ﹤0.01% 1813
2020
Q2
$1.76M Sell
46,584
-3,562
-7% -$134K ﹤0.01% 1801
2020
Q1
$1.45M Buy
50,146
+2,507
+5% +$72.5K ﹤0.01% 1716
2019
Q4
$2.47M Buy
47,639
+2,756
+6% +$143K ﹤0.01% 1680
2019
Q3
$2.46M Buy
44,883
+1,765
+4% +$96.9K ﹤0.01% 1618
2019
Q2
$1.75M Buy
43,118
+580
+1% +$23.6K ﹤0.01% 1819
2019
Q1
$1.29M Buy
42,538
+366
+0.9% +$11.1K ﹤0.01% 1914
2018
Q4
$1.42M Buy
42,172
+6,080
+17% +$204K ﹤0.01% 1845
2018
Q3
$1.52M Buy
36,092
+244
+0.7% +$10.3K ﹤0.01% 1806
2018
Q2
$1.15M Buy
35,848
+1,972
+6% +$63.1K ﹤0.01% 1950
2018
Q1
$1.68M Buy
33,876
+695
+2% +$34.5K ﹤0.01% 1702
2017
Q4
$1.79M Buy
33,181
+4,836
+17% +$261K ﹤0.01% 1687
2017
Q3
$1.64M Buy
28,345
+625
+2% +$36.3K ﹤0.01% 1727
2017
Q2
$1.37M Buy
27,720
+96
+0.3% +$4.74K ﹤0.01% 1779
2017
Q1
$1.2M Buy
27,624
+8,169
+42% +$355K ﹤0.01% 1831
2016
Q4
$953K Buy
19,455
+520
+3% +$25.5K ﹤0.01% 1875
2016
Q3
$906K Buy
18,935
+1,265
+7% +$60.5K ﹤0.01% 1866
2016
Q2
$948K Sell
17,670
-905
-5% -$48.6K ﹤0.01% 1814
2016
Q1
$831K Buy
18,575
+585
+3% +$26.2K ﹤0.01% 1911
2015
Q4
$686K Buy
17,990
+1,210
+7% +$46.1K ﹤0.01% 2048
2015
Q3
$534K Buy
16,780
+191
+1% +$6.08K ﹤0.01% 2180
2015
Q2
$548K Buy
16,589
+75
+0.5% +$2.48K ﹤0.01% 2265
2015
Q1
$680K Buy
16,514
+2,025
+14% +$83.4K ﹤0.01% 2106
2014
Q4
$590K Sell
14,489
-350
-2% -$14.3K ﹤0.01% 2176
2014
Q3
$544K Buy
14,839
+450
+3% +$16.5K ﹤0.01% 2155
2014
Q2
$667K Sell
14,389
-561
-4% -$26K ﹤0.01% 2085
2014
Q1
$614K Sell
14,950
-590
-4% -$24.2K ﹤0.01% 2084
2013
Q4
$593K Buy
15,540
+2,550
+20% +$97.3K ﹤0.01% 2150
2013
Q3
$311K Buy
12,990
+18
+0.1% +$431 ﹤0.01% 2504
2013
Q2
$221K Buy
+12,972
New +$221K ﹤0.01% 2915